Addison Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Buy |
5,443
+734
| +16% | +$28.2K | 0.05% | 213 |
|
|
2025
Q1 | $182K | Buy |
4,709
+411
| +10% | +$15.9K | 0.05% | 220 |
|
|
2024
Q4 | $145K | Buy |
4,298
+266
| +7% | +$9K | 0.04% | 251 |
|
|
2024
Q3 | $165K | Buy |
4,032
+253
| +7% | +$10.3K | 0.05% | 244 |
|
|
2024
Q2 | $145K | Buy |
3,779
+67
| +2% | +$2.58K | 0.05% | 244 |
|
|
2024
Q1 | $159K | Buy |
3,712
+10
| +0.3% | +$429 | 0.05% | 224 |
|
|
2023
Q4 | $137K | Buy |
3,702
+395
| +12% | +$14.6K | 0.05% | 235 |
|
|
2023
Q3 | $120K | Buy |
3,307
+432
| +15% | +$15.7K | 0.06% | 224 |
|
|
2023
Q2 | $102K | Buy |
2,875
+314
| +12% | +$11.2K | 0.05% | 242 |
|
|
2023
Q1 | $91.1K | Sell |
2,561
-7
| -0.3% | -$249 | 0.05% | 236 |
|
|
2022
Q4 | $90.2K | Buy |
2,568
+2,152
| +517% | +$75.6K | 0.05% | 227 |
|
|
2022
Q3 | $12K | Buy |
+416
| New | +$12K | 0.01% | 423 |
|
|
2022
Q2 | – | Sell |
-1,510
| Closed | -$82K | – | 709 |
|
|
2022
Q1 | $82K | Buy |
1,510
+1,243
| +466% | +$67.5K | 0.04% | 226 |
|
|
2021
Q4 | $15K | Buy |
267
+135
| +102% | +$7.58K | 0.01% | 371 |
|
|
2021
Q3 | $6K | Sell |
132
-181
| -58% | -$8.23K | ﹤0.01% | 339 |
|
|
2021
Q2 | $16K | Buy |
+313
| New | +$16K | 0.01% | 272 |
|
|
2020
Q4 | $16K | Buy |
+345
| New | +$16K | 0.02% | 258 |
|